• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Letrozole linked to lower rate of multiple gestation and live birth vs gonadotropin: The AMIGOS study

byMatthew Lin, MDandShaidah Deghan, MSc. MD
September 24, 2015
in Obstetrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The rate of multiple clinical pregnancy was significantly higher in patients treated with gonadotropin compared to treatment groups with clomiphene or letrozole.

2. The rate of multiple gestation was not significantly reduced in women in the letrozole group compared to women in either the clomiphene or gonadotropin group.

Evidence Rating: 1 (Excellent)  

Study Rundown: For patients with unexplained infertility, empirical ovarian stimulation combined with intrauterine insemination is one therapeutic option. The standard treatment regimen in ovarian stimulation for these patients – clomiphene citrate and/or gonadotropin – pose the risk of ovarian hyperstimulation, resulting in multiple gestations. In this randomized trial, researchers evaluated the frequency of multiple gestations and live births resulting from use of letrozole, an aromatase inhibitor, compared to those of clomiphene or gonadotropin. Their results demonstrated that letrozole resulted in the lowest rate of live births compared to the clomiphene and gonadotropin groups. Additionally, gonadotropin use resulted in a higher rate of multiple gestations compared to the use of either letrozole or clomiphene alone. Limitations of this study include possible bias from lack of blinding for the gonadotropin group.

Click to read the study, published today in NEJM

Relevant Reading: Ovarian stimulation and intrauterine insemination at the quarter centennial: implications for the multiple births epidemic

RELATED REPORTS

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

Letrozole and abemaciclib in estrogen receptor–positive recurrent endometrial cancer

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers

In-Depth [randomized controlled trial]: In this multicenter randomized trial – The Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) – researchers analyzed data from 900 couples with unexplained infertility. Patients were women between 18-40 years of age with ≥9 menstrual cycles per year, normal uterine cavities with at least one patent fallopian tube and had a male partner with a semen specimen of at least 5 million sperm/mL. The participants were randomized to either receive clomiphene, gonadotropin, or letrozole. The primary study outcome was the rate of multiple gestations. Secondary outcomes included rates of live birth, multiple gestation with live birth, pregnancy loss, length of gestation and maternal-fetal and neonatal complications. Treatment with gonadotropin yielded a statistically significant higher rate of live births (32.2%) compared to clomiphene (23.3%) and letrozole (18.7%), p<0.003. Gonadotropin demonstrated a higher rate of cumulative serious adverse effects compared to the letrozole and clomiphene groups (p=0.009).

In terms of multiple gestations, patients receiving gonadotropin had significantly more multiple gestations compared with clomiphene or letrozole. However, in comparing gonadotropin and clomiphene as a combined group, versus patients receiving letrozole, there was no significant difference in multiple gestations (p=0.15). Lastly, there were no significant differences in secondary outcomes.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: letrozole
Previous Post

Cortical volumes in African Americans with type 2 diabetes correlated with cognitive function

Next Post

Insertion site associated with catheter-related complications: The 3SITES study

RelatedReports

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation
StudyGraphics

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

January 31, 2023
Recurrence of endometrial hyperplasia following medical therapy is common
Oncology

Letrozole and abemaciclib in estrogen receptor–positive recurrent endometrial cancer

December 28, 2022
#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers
StudyGraphics

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers

August 2, 2022
#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage
StudyGraphics

#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage

July 19, 2022
Next Post
Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients

Insertion site associated with catheter-related complications: The 3SITES study

MRI reveals evolution of cerebral microhemorrhages in traumatic brain injury

MRI reveals evolution of cerebral microhemorrhages in traumatic brain injury

Active surveillance in favorable-risk prostate cancer associated with low long-term mortality

Active surveillance in favorable-risk prostate cancer associated with low long-term mortality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
  • Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.